Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
4.000
-0.320 (-7.41%)
At close: Oct 9, 2026, 4:00 PM EDT
3.400
-0.600 (-15.00%)
After-hours: Oct 9, 2026, 7:43 PM EDT
Niki BioSolutions Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
11.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | 911.51K | 376.34K | 70.32% |
| Dec 31, 2019 | 535.17K | 151.72K | 39.57% |
| Dec 31, 2018 | 383.45K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cerenome | 4.20M |
| BioLineRx | 1.39M |
| Daré Bioscience | 1.37M |
| Pluri | 1.02M |
| CytoMed Therapeutics | 609.73K |
NIKI News
- 15 days ago - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 26 days ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 4 weeks ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Niki BioSolutions files $75M mixed securities shelf - TheFly
- 2 months ago - Aptorum Group Provides Update on DiamiR Biosciences Merger - GlobeNewsWire
- 3 months ago - Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference - GlobeNewsWire
- 3 months ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 3 months ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp